The Placebo Effect in Agoraphobia
- 1 February 1987
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Nervous & Mental Disease
- Vol. 175 (2) , 95-99
- https://doi.org/10.1097/00005053-198702000-00005
Abstract
This paper presents two sets of data that suggest a weak but specific placebo response in agoraphobia. First, analyses in 20 agoraphobic patients given single-blind placebo over a 2-week period, without the customary confound of instructions for exposure to phobic situations, revealed a statistically significant reduction in panic and phobic symptoms. However, symptoms remained in the moderate to severe range and functioning was virtually unchanged. Second, comparisons between six agoraphobic patients receiving double-blind placebo and six others receiving "no pills", matched for age, sex, and exposure treatment, revealed a significant placebo effect over an 8-week period. Implications for clinical research are briefly discussed.This publication has 6 references indexed in Scilit:
- AGORAPHOBIA - RELATIVE AND COMBINED EFFECTIVENESS OF THERAPIST-ASSISTED INVIVO EXPOSURE AND IMIPRAMINE1986
- Imipramine in the treatment of agoraphobia: dose-response relationshipsAmerican Journal of Psychiatry, 1985
- Psychotherapy outcome research: Methods for reporting variability and evaluating clinical significanceBehavior Therapy, 1984
- Self-directed in vivo exposure practice in behavioral and pharmacological treatments of agoraphobiaBehavior Therapy, 1983
- Brief standard self-rating for phobic patientsBehaviour Research and Therapy, 1979
- An Inventory for Measuring DepressionArchives of General Psychiatry, 1961